Remove Life Sciences Remove Pharmaceuticals Remove Prevention
article thumbnail

Digiceuticals: Driving Growth Through Digital Health Services

HIT Consultant

Subhro Mallik, SVP & Head of Life Sciences at Infosys. The new normal has thrown up opportunities as well as risks for pharmaceutical companies. The application of digital technologies in pharmaceuticals – digiceuticals – is a promising way forward. There was tremendous interest in telemedicine before 2020.

article thumbnail

Is making mRNA vaccines for infectious diseases profitable?

Healthcare ECONOMIST

The figure below shows that as the Delta and Omicron variants spread in the fall of 2021, COVID-19 vaccines prevented significant number of deaths according to Vox. Despite these positive impacts, a number of political commentators have accused pharmaceutical companies of profiteering. A study by Ahuja et al. A study by Ahuja et al.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

HeartMates, Bringing Community and Heart Health Love from Damar Hamlin – Abbott at #CES2024

Health Populi

Abbott, one of the first life science companies to exhibit at CES back in 2022, announced the HeartMates program here at #CES2024 today as part of a panel titled Ahead of the Game: Revolutionizing Athlete Safety with Emerging Health Tech.

article thumbnail

McKinsey’s Six Shifts To Add Life to Years — and One More to Consider

Health Populi

This led the team to identify six shifts that, implemented together, could add those 45 billion more years of quality life to extended life expectancy: those shifts are, To invest more and disproportionately on prevention and health promotion.

article thumbnail

Partnering Up in the Health Care Ecosystem to Drive Transformation – for Organizations and Health Consumers Alike

Health Populi

And that data will be generated from many sources, frequently siloed and decentralized which can prevent aggregation, mash-up, and analysis. We’re talking about a team sport here — to most effectively benefit patients’ outcomes from prevention through diagnosis and treatment.

article thumbnail

Why #CES2022 Will Be Keynoted By A Health Care Innovator for the First Time

Health Populi

That a pharmaceutical company executive is speaking on the main stage at CES speaks to digital health’s mainstreaming beyond elite athletes and smartwatches that track activity.

article thumbnail

Pharma & Influencer Marketing: Can They Coexist Ethically?

HIT Consultant

Mike Szczesny, Owner & VP of EDCO Awards & Specialties Influencer marketing in the pharmaceutical industry is a complex issue with reasonable arguments on multiple sides. On the one hand, leveraging individual patients’ personal experiences and narratives may help bring an authentic voice to product messaging.